English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18033/20233 (89%)
造訪人次 : 23241189      線上人數 : 314
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/31707


    標題: Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance
    作者: Ku, Yee-Huang
    Chen, Chi-Chung
    Lee, Mei-Feng
    Chuang, Yin-Ching
    Tang, Hung-Jen
    Yu, Wen-Liang
    貢獻者: Chi Mei Med Ctr, Div Infect Dis, Dept Internal Med
    Chi Mei Med Ctr, Dept Med Res
    Chi Mei Hosp, Div Infect Dis, Dept Internal Med
    Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
    Chi Mei Med Ctr, Dept Intens Care Med
    Taipei Med Univ, Dept Med, Sch Med, Coll Med
    關鍵字: Carbapenem resistance
    Colistin
    ESBL
    Fosfomycin
    Tigecycline
    日期: 2017-12
    上傳時間: 2018-11-30 15:53:41 (UTC+8)
    出版者: Elsevier Taiwan
    摘要: Purpose: To investigate the synergistic and bactericidal effects of antimicrobial combinations of any two of colistin, fosfomycin and tigecycline against the nine extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae (KP) clinical isolates, including 4 carbapenem-susceptible strains and five imipenem and/or meropenem-resistant strains. Methods: In vitro synergism and bactericidal activity of combination of colistin, fosfomycin and tigecycline were evaluated by time-kill studies in standard inoculum of bacterial densities of a suspension containing 5 x 10(5) CFU/mL by using 1/2 x MIC for each alone, and both 1/2 x and 1/4 x MIC for any two drugs. The settings of low MIC dosing were allowed to rapidly survey the most active drug combination. Results: The most active combination group was colistin plus tigecycline, showing synergy in 8 isolates and bactericidal activities in 6 isolates by using concentrations of 1/2 x MIC and 1/4 xMIC, respectively. The least active combination was tigecycline plus fosfomycin, which showed synergy in only 4 isolates and no bactericidal activities by using concentrations of 1/2 x MIC and 1/4 x MIC, respectively. Conclusions: The combination of tigecycline and colistin may be considered as a last-resort approach to the ESBL-producing KP infections, especially those isolates with carbapenem resistance. Copyright (c) 2017, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
    關聯: Journal of Microbiology Immunology and Infection, v.50, n.6, pp.931-939
    顯示於類別:[保健營養系(所) ] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML1295檢視/開啟
    j.jmii.2016.12.008.pdf1242KbAdobe PDF0檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋